About Pr Pharma Source
Pr Pharma Source is a Healthcare company. Pharmaceutical manufacturing, exporting, and supply services in India. Its Indian entity P R Pharma Source Private Limited reported revenue of ₹56.27 Cr. Pr Pharma Source offers products and services including Pellets and APIs. Its focus areas include Pharmaceuticals, Drug Manufacturing, Pellets Production and Export Services.
Company details
Pr Pharma Source Is Identified As A Key Entity In The Pharmaceutical Sector, Where Various Types Of Pharma Pellets Are Manufactured In Gmp-certified And Who-compliant Facilities Located In North India. Exclusive Partnerships With 12 Manufacturing Companies Enable The Export Of Products Such As Apis, Excipients, And Formulation Chemicals. A Basket-based Strategy Is Employed To Ensure Efficient And Timely Deliveries, While Adherence To Patent Regulations Is Maintained By Not Supplying Products To Conflicting Countries. The Company Operates From Mumbai, Emphasizing Quality And Compliance In All Operations.
- SectorsHealthcare
- Email••••••••
- Legal Name Pr Pharma Source Pvt Ltd
- Date of Incorporation 16 Jun, 2007
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹56.27 Cr
FY 2025 · -6% YoY
- Indian entity net profit₹43.3 Lakh
FY 2025 · 1% margin
- Indian entity EBITDA₹65.9 Lakh
FY 2025 · 1% margin
Associated legal entities of Pr Pharma Source
Pr Pharma Source operates through P R Pharma Source Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| P R Pharma Source Private Limited CIN U52311MH2007PTC171721 | Active | 16 Jun 2007 | Mumbai, Maharashtra | ₹56.3 Cr | 2 | View details |
Products & Services of Pr Pharma Source
Pr Pharma Source offers a comprehensive portfolio of products and services, including Pellets and APIs.
Various types of pharma pellets are manufactured in GMP-certified facilities
APIs are supplied through partnerships with manufacturing companies
Board of directors of P R Pharma Source Private Limited (Pr Pharma Source)
P R Pharma Source Private Limited is the primary company behind Pr Pharma Source. The board of P R Pharma Source Private Limited currently have 2 directors; the longest-serving is Paresh Shantilal Bagadia, appointed in 2007. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Paresh Shantilal Bagadia DIN 01636125 | Managing Director | 16 Jun 2007 | 19 yrs 4 mo | P R Pharma Source Private Limited |
| Kaushik Mahendra Mehta DIN 06415149 | Additional Director | 06 Jul 2013 | 13 yrs 3 mo | P R Pharma Source Private Limited |
Financials of Pr Pharma Source
Figures of P R Pharma Source Private Limited, the primary company behind Pr Pharma Source, for FY 2025. Revenue was ₹56.27 Cr (-6% year on year). Net profit was ₹43.3 Lakh (1% margin). EBITDA was ₹65.9 Lakh (1% margin). Revenue has grown at a compounded annual rate of -12% over three years and +2% over five years.
- ₹56.27 CrRevenue · FY 2025 · -6% YoY
- ₹43.3 LakhNet profit · 1% margin
- ₹65.9 LakhEBITDA · 1% margin
- ₹50 LakhPaid-up capital
- -12%Revenue CAGR, 3 years
- +2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of P R Pharma Source Private Limited are on its company page.
Detailed financial statements for Pr Pharma Source
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pr Pharma Source
The primary company behind Pr Pharma Source, P R Pharma Source Private Limited, reported revenue of ₹56.27 Cr for FY 2025, down 6% year on year.
Pr Pharma Source Is Identified As A Key Entity In The Pharmaceutical Sector, Where Various Types Of Pharma Pellets Are Manufactured In Gmp-certified And Who-compliant Facilities Located In North India. Exclusive Partnerships With 12 Manufacturing Companies Enable The Export Of Products Such As Apis, Excipients, And Formulation Chemicals. A Basket-based Strategy Is Employed To Ensure Efficient And Timely Deliveries, While Adherence To Patent Regulations Is Maintained By Not Supplying Products To Conflicting Countries. The Company Operates From Mumbai, Emphasizing Quality And Compliance In All Operations.
Pr Pharma Source offers Pellets and APIs.
Pr Pharma Source operates through P R Pharma Source Private Limited.
The legal entities of Pr Pharma Source currently have 2 directors, including Paresh Shantilal Bagadia, Kaushik Mahendra Mehta.